Treatment-related dysgeusia in head and neck cancer patients.

Abstract

Head and neck cancer patients treated with radiotherapy and/or chemotherapy agents may develop altered taste acuity. This, together with radiation induced xerostomia and dysphagia, is a major contributory factor to the anorexia and concomitant morbidity often seen in this group of patients. This paper examines the existing literature in order to assess the prevalence of clinician and patient-reported dysgeusia in HNC patients undergoing oncological treatment. We also describe the temporal manifestations of the same and its reported impact on QOL.

• Authors: Ekpemi Irune, Raghav C Dwivedi, Christopher M Nutting, Kevin J Harrington
• Journal: Cancer treatment reviews (Cancer Treat Rev) Vol. 40 Issue 9 Pg. 1106-17 (Oct 2014) ISSN: 1532-1967 [Electronic] Netherlands
• PMID: 25064135 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2014 Elsevier Ltd. All rights reserved.

Chemical References

• Antineoplastic Agents

Topics

• Antineoplastic Agents (adverse effects)
• Dose-Response Relationship, Radiation
• Dysgeusia (epidemiology, etiology)
• Head and Neck Neoplasms (radiotherapy, therapy)
• Humans
• Quality of Life
• Radiotherapy (adverse effects)
• Taste
• Xerostomia (etiology)